Form 4: STERIS plc Executive Julia Madsen Reports Stock Option Exercise and Sale

Julia Madsen, Senior VP of Life Sciences at STERIS plc, reports exercising stock options and selling shares on June 5, 2024.

Summary

• On June 5, 2024, Julia Madsen, Senior VP of Life Sciences at STERIS plc, exercised stock options to acquire 400 shares at $69.72 and 3,252 shares at $77.07.
• Simultaneously, she sold 400 shares at $230 and 3,252 shares at $230.
• Following these transactions, Madsen directly owns 9,671 ordinary shares of STERIS plc, including 4,483 restricted shares that will vest at various dates in the future.
• She also holds options to purchase 2,700 shares at $69.72 (expiring June 1, 2026) and 3,252 shares at $77.07 (expiring May 30, 2027).

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It's a standard practice for publicly traded companies and their officers.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The details provided in this filing are consistent with the requirements of Section 16(a) of the Securities Exchange Act of 1934.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates